S
Zodix
Study
Academic Library
Search
Dashboard
Shelves
Open access
My library
Inbox
Notes
Write
Learn
Alerts
More
Ask your library
Notifications
Quick cite
Review
Search or jump to…
⌘K
Joseph A. DiMasi · Study
Home
/
Author
Joseph A. DiMasi
21 works
· latest 2016
· 1 institutions
cluster: provisional
ORCID 0000-0002-3432-6928
Follow
Suggest an ORCID correction
h-index
21
i10
21
Citations
13,008
Works here
21
91
95
00
01
02
03
04
07
09
10
13
15
16
Most cited in this library
The price of innovation: new estimates of drug development costs
2003 · 4,264 citations
Innovation in the pharmaceutical industry: New estimates of R&D costs
2016 · 3,352 citations
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
2010 · 847 citations
Cost of innovation in the pharmaceutical industry
1991 · 763 citations
The cost of biopharmaceutical R&D: is biotech different?
2007 · 517 citations
Works
21 shown
Innovation in the pharmaceutical industry: New estimates of R&D costs
Journal of Health Economics
·
2016
·
3 authors
·
Open access
3,352
citations
The Cost of Drug Development
New England Journal of Medicine
·
2015
·
3 authors
·
Open access
121
citations
The Roles Of Patents And Research And Development Incentives In Biopharmaceutical Innovation
Health Affairs
·
2015
·
3 authors
·
Open access
77
citations
Clinical Approval Success Rates for Investigational Cancer Drugs
Clinical Pharmacology & Therapeutics
·
2013
·
3 authors
203
citations
Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009
Clinical Pharmacology & Therapeutics
·
2010
·
2 authors
329
citations
Competitiveness in follow-on drug R&D: a race or imitation?
Nature Reviews Drug Discovery
·
2010
·
2 authors
95
citations
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
Clinical Pharmacology & Therapeutics
·
2010
·
2 authors
847
citations
Drug development costs when financial risk is measured using the Fama–French three‐factor model
Health Economics
·
2009
·
3 authors
108
citations
The cost of biopharmaceutical R&D: is biotech different?
Managerial and Decision Economics
·
2007
·
2 authors
·
Open access
517
citations
Economics of New Oncology Drug Development
Journal of Clinical Oncology
·
2007
·
2 authors
·
Open access
348
citations
R&D Costs and Returns by Therapeutic Category
Drug Information Journal
·
2004
·
2 authors
·
Open access
119
citations
The Economics of Follow-on Drug Research and Development
PharmacoEconomics
·
2004
·
2 authors
189
citations
The price of innovation: new estimates of drug development costs
Journal of Health Economics
·
2003
·
3 authors
·
Open access
4,264
citations
Returns on Research and Development for 1990s New Drug Introductions
PharmacoEconomics
·
2002
·
2 authors
311
citations
The Value of Improving the Productivity of the Drug Development Process
PharmacoEconomics
·
2002
·
1 author
233
citations
Risks in new drug development: Approval success rates for investigational drugs
Clinical Pharmacology & Therapeutics
·
2001
·
1 author
450
citations
New drug development in the United States from 1963 to 1999
Clinical Pharmacology & Therapeutics
·
2001
·
1 author
251
citations
New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms
Drug Information Journal
·
2000
·
1 author
78
citations
Success rates for new drugs entering clinical testing in the United States
Clinical Pharmacology & Therapeutics
·
1995
·
1 author
184
citations
Research and Development Costs for New Drugs by Therapeutic Category
PharmacoEconomics
·
1995
·
4 authors
169
citations
Cost of innovation in the pharmaceutical industry
Journal of Health Economics
·
1991
·
4 authors
·
Open access
763
citations